Cargando…

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

The impact of the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting strain on downstream immunity to heterologous variants of concern (VOCs) is unknown. Studying a longitudinal healthcare worker cohort, we found that after three antigen exposures (infection plus two vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reynolds, Catherine J., Gibbons, Joseph M., Pade, Corinna, Lin, Kai-Min, Sandoval, Diana Muñoz, Pieper, Franziska, Butler, David K., Liu, Siyi, Otter, Ashley D., Joy, George, Menacho, Katia, Fontana, Marianna, Smit, Angelique, Kele, Beatrix, Cutino-Moguel, Teresa, Maini, Mala K., Noursadeghi, Mahdad, Brooks, Tim, Semper, Amanda, Manisty, Charlotte, Treibel, Thomas A., Moon, James C., McKnight, Áine, Altmann, Daniel M., Boyton, Rosemary J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186585/ https://www.ncbi.nlm.nih.gov/pubmed/34855510 http://dx.doi.org/10.1126/science.abm0811

Ejemplares similares

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
por: Reynolds, Catherine J., et al.
Publicado: (2021)

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
por: Altmann, Daniel M., et al.
Publicado: (2023)

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
por: Manisty, Charlotte, et al.
Publicado: (2021)

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
por: Manisty, Charlotte, et al.
Publicado: (2021)

Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply
por: Treibel, Thomas A, et al.
Publicado: (2020)

Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
por: Doykov, Ivan, et al.
Publicado: (2022)

COVID-19: PCR screening of asymptomatic health-care workers at London hospital
por: Treibel, Thomas A, et al.
Publicado: (2020)

Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
por: Gupta, Rishi K, et al.
Publicado: (2021)

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
por: Captur, Gabriella, et al.
Publicado: (2022)

HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
por: Astbury, Stuart, et al.
Publicado: (2022)

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
por: Reynolds, Catherine J., et al.
Publicado: (2020)

Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
por: Chandran, Aneesh, et al.
Publicado: (2022)

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
por: Milighetti, Martina, et al.
Publicado: (2023)

COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
por: Milojkovic, Dragana, et al.
Publicado: (2022)

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
por: Swadling, Leo, et al.
Publicado: (2021)

Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.
por: Valdes, Ana M., et al.
Publicado: (2021)

Curbside particulate matter and susceptibility to SARS–CoV-2 infection
por: Miyashita, Lisa, et al.
Publicado: (2023)

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
por: Reynolds, Catherine J., et al.
Publicado: (2022)

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19
por: Usai, Carla, et al.
Publicado: (2022)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly, et al.
Publicado: (2013)

The Right ventricle and cardiac surgery - more resilient than thought: multiparametric quantification shows altered rather than reduced function
por: Medina, Katia D Menacho, et al.
Publicado: (2016)

Clinical academic research in the time of Corona: A simulation study in England and a call for action
por: Banerjee, Amitava, et al.
Publicado: (2020)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly M, et al.
Publicado: (2014)

Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers
por: Joy, George, et al.
Publicado: (2021)

Immunopathogenesis of Severe Sepsis
por: Noursadeghi, Mahdad, et al.
Publicado: (2000)

Interactions between HIV-1 and the Cell-Autonomous Innate Immune System
por: Towers, Greg J., et al.
Publicado: (2014)

Does tuberculosis threaten our ageing populations?
por: Byng-Maddick, Rachel, et al.
Publicado: (2016)

New Insights into the Limitations of Host Transcriptional Biomarkers of Tuberculosis
por: Noursadeghi, Mahdad, et al.
Publicado: (2021)

Toward a more generalizable blood RNA signature for bacterial and viral infections
por: Gupta, Rishi K., et al.
Publicado: (2022)

Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial
por: Jolliffe, David A., et al.
Publicado: (2022)

Streptococcus pneumoniae interactions with the complement system
por: Gil, Eliza, et al.
Publicado: (2022)

Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19
por: Augusto, João B, et al.
Publicado: (2020)

Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19
por: Harrington, David, et al.
Publicado: (2021)

Streptococcus pneumoniae meningitis and the CNS barriers
por: Gil, Eliza, et al.
Publicado: (2023)

Are the public getting the message about antimicrobial resistance?
por: Shallcross, Laura J, et al.
Publicado: (2015)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
por: Boyton, Rosemary J., et al.
Publicado: (2021)

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mv6pf1ggd7asu6vo3bc71olo89